MedTrace Logo

Low Dose Ketamine (LDK) Versus Morphine for Acute Pain Control in the Emergency Department

NCT01538745 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2021-02-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the safety and effectiveness of intravenous low dose ketamine (LDK) to the industry standard of morphine (MOR) in regards to controlling acute pain in the emergency department.

Both LDK and morphine have side effects. The amount and character of these side effects will be compared. Additionally, the degree of sedation or agitation will be specifically measured. The aim of this current study is to make this comparison and shift the evidence for LDK use from the anecdotal to the scientific.

Conditions

Interventions

DRUG

Ketamine

0.3 mg/kg ketamine Intravenous push (IVP) over 5 minutes. Total of two possible doses.

DRUG

Morphine

0.1 mg/kg Morphine IVP over 5 minutes. Total of two possible doses.

Sponsors & Collaborators

  • U.S. Air Force Office of the Surgeon General

    collaborator FED

  • Brooke Army Medical Center

    lead FED

Principal Investigators

  • Joshua P Miller, MD · United States Air Force

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-03-31
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01538745 on ClinicalTrials.gov